Screening for ischemia in asymptomatic diabetic patient should not be systematic but rather performed in a populatio selected according to the following criteria: abnormalities of basal ECG; >= 2 cardiovascular risk factors or an organ damage and high coronary artery calcium score; when physical activity is newly planned. When ischemia is identified, cardiovascular risk factors shoul be better controlled, anti-ischemic treatment optimized an coronary stenoses identified to be revascularized: by-pass i case of trivascular stenoses, angioplasty in case of coronar stenosis with downstream ischemia
Clinical Research. Presentation type: Oral Presentation. Introduction: Coronary artery disease (CAD)...
Aims: The cost-effectiveness of screening for silent coronary heart disease (CHD) in type 2 diabetes...
International audienceBackground: Screening for silent coronary artery disease in asymptomatic patie...
National audienceScreening for ischemia in asymptomatic diabetic patient should not be systematic bu...
Coronary artery disease (CAD) accounts for 65% to 80% of deaths in diabetic patients. The merits of ...
BackgroundA common argument for identifying SMI in asymptomatic diabetic patients is to intensify tr...
SummaryBackgroundScreening for silent myocardial ischaemia (SMI) is a controversial strategy undergo...
Objective Despite the association of diabetes mellitus type 2 (DM2) with silent myocardial ischaemia...
Silent ischaemia is a common, under-recognised condition that is associated with an adverse prognosi...
Screening of silent myocardial ischaemia in type 2 diabetic patients with additional atherogenic ris...
P atients with type 2 diabetes suffertwice the cardiovascular mortality ofpatients without the disea...
OBJECTIVE—To evaluate if silent myocardial ischemia (SMI) and silent coronary artery dis-ease (CAD) ...
OBJECTIVE — To assess the prevalence and clinical predictors of silent myocardial ischemia in asympt...
diabetes mellitus is a coronary artery disease (CAD) [5,6], these observations have raised the quest...
ABSTRACT Diabetes is a very frequent disease and it is estimated that its prevalence will continuous...
Clinical Research. Presentation type: Oral Presentation. Introduction: Coronary artery disease (CAD)...
Aims: The cost-effectiveness of screening for silent coronary heart disease (CHD) in type 2 diabetes...
International audienceBackground: Screening for silent coronary artery disease in asymptomatic patie...
National audienceScreening for ischemia in asymptomatic diabetic patient should not be systematic bu...
Coronary artery disease (CAD) accounts for 65% to 80% of deaths in diabetic patients. The merits of ...
BackgroundA common argument for identifying SMI in asymptomatic diabetic patients is to intensify tr...
SummaryBackgroundScreening for silent myocardial ischaemia (SMI) is a controversial strategy undergo...
Objective Despite the association of diabetes mellitus type 2 (DM2) with silent myocardial ischaemia...
Silent ischaemia is a common, under-recognised condition that is associated with an adverse prognosi...
Screening of silent myocardial ischaemia in type 2 diabetic patients with additional atherogenic ris...
P atients with type 2 diabetes suffertwice the cardiovascular mortality ofpatients without the disea...
OBJECTIVE—To evaluate if silent myocardial ischemia (SMI) and silent coronary artery dis-ease (CAD) ...
OBJECTIVE — To assess the prevalence and clinical predictors of silent myocardial ischemia in asympt...
diabetes mellitus is a coronary artery disease (CAD) [5,6], these observations have raised the quest...
ABSTRACT Diabetes is a very frequent disease and it is estimated that its prevalence will continuous...
Clinical Research. Presentation type: Oral Presentation. Introduction: Coronary artery disease (CAD)...
Aims: The cost-effectiveness of screening for silent coronary heart disease (CHD) in type 2 diabetes...
International audienceBackground: Screening for silent coronary artery disease in asymptomatic patie...